Default: British Journal of Clinical Pharmacology

ISSN: 0306-5251

Journal Home

Journal Guideline

British Journal of Clinical Pharmacology Q1 Unclaimed

Wiley-Blackwell Publishing Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

British Journal of Clinical Pharmacology is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 146. It has a price of 3429 €. It has an SJR impact factor of 1,216 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,216.

British Journal of Clinical Pharmacology focuses its scope in these topics and keywords: drug, healthy, review, study, acid, systematic, prescribing, oral, comparison, design, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

3429 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

British Journal of Clinical Pharmacology

1,216

SJR Impact factor

146

H Index

366

Total Docs (Last Year)

947

Total Docs (3 years)

14447

Total Refs

3232

Total Cites (3 years)

796

Citable Docs (3 years)

3,19

Cites/Doc (2 years)

39,47

Ref/Doc

Aims and Scope


drug, healthy, review, study, acid, systematic, prescribing, oral, comparison, design, primary, release, amino, active, ulcerative, metaanalysis, home, preparation, potentially, effectiveness, cysteamine, pharmacokinetics, inappropriate, inhibitors, current, nursing, parkinsons, pharmacovigilance, plasma,



Best articles by citations

Quinine intoxications reported to the Scottish Poisons Information Bureau 1997-2002: a continuing problem

View more

Nonspecific binding of drugs to human liver microsomes

View more

The regulation of medical devices and the role of the Medical Devices Agency

View more

Indicators for Drug and Therapeutics Committees

View more

Population PK and PK/PD modelling of microencapsulated octreotide acetate in healthy subjects

View more

Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride

View more

Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients

View more

Inhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalysed by human CYP1A2

View more

Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors

View more

Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis

View more

Plasma protein binding displacement interactions-why are they still regarded as clinically important?

View more

beta-adrenoceptor blockers and pulmonary function in the general population: the Rotterdam Study

View more
SHOW MORE ARTICLES

Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population

View more

The airway effects of stopping regular oral theophylline in patients with asthma

View more

Diflunisal: efficacy in postoperative pain.

View more

Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study

View more

The passage of cloxacillin into cerebrospinal fluid in the absence of meningitis.

View more

The effects of KT3-671, a new angiotensin II (AT 1) receptor blocker in mild to moderate hypertension

View more

Expanded Access as a source of real-world data: An overview of FDA and EMA approvals

View more

The influence of the hand circulation on the assessment of venous distensibility of the human forearm with venous occlusion plethysmography

View more

The efficacy of parecoxib on systemic inflammatory response associated with cardiopulmonary bypass during cardiac surgery

View more

Ultramolecular homeopathy has no observable clinical effects. A randomized, double-blind, placebo-controlled proving trial of Belladonna 30C

View more

Drugs Handbook 2003

View more

Variability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteers

View more

Comments

No comments ... Be the first to comment!

FAQS